Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
N. Alebrahimdehkordi (Giessen, Germany), O. Pak (Giessen, Germany), S. Scheibe (Giessen, Germany), M. Gierhardt (Giessen, Germany), A. Sydykov (Giessen, Germany), M. Hecker (Giessen, Germany), K. Schaefer (Giessen, Germany), W. Seeger (Giessen, Germany), H. Ghofrani (Giessen, Germany), R. Schermuly (Giessen, Germany), M. Murphy (Cambridge, United Kingdom), N. Weissmann (Giessen, Germany), N. Sommer (Giessen, Germany). Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension. 1416

Member's Comments

No comment yet.

Related content which might interest you: Functional upregulation of PRMT2 in chronic hypoxia-induced pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004 Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension Source: Eur Respir J, 51 (3) 1701024; 10.1183/13993003.01024-2017 Year: 2018 Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006 Sirt3-MnSOD signaling pathway attenuates airway epithelial mitochondrial oxidative stress in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Extracellular superoxide dismutase (EC-SOD) as a protective factor for risk of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006 Estradiol exacerbates superoxide-induced nitrative lung injury and pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Shroom expression is attenuated in hypoxia-induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006 Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 276 Year: 2009 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001 MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021 Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020 Year: 2020 Interaction between mitochondrial ROS and ER stress on PHMG-induced pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients Source: Eur Respir J 2009; 33: 1309-1319 Year: 2009 2-Methoxyestrone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 The effect of mtTFA methylation in the pathogenesis of pulmonary vascular endothelial cell apoptosis of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 2-Ethoxyestradiol inhibits vascular and cardiac remodeling and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007